Home   Contact Us   Sitemap



 Press Releases  Indoco In News  Industry News
 
 
Press Releases :
 

Indoco acquires Manufacturing plant in Baddi
September 21, 2016
Indoco Remedies receives USFDA nod for its manufacturing facility (Goa Plant II)
May 25, 2016
Indoco Remedies receives USFDA nod for solid dosages Plant I in Goa
March 21, 2016
Indoco acquires Piramal's Clinical Research Division
April 01, 2015
Indoco Remedies gets USFDA nod for Goa's sterile and solid dosage facilities
July 21, 2014
Mr. Suresh G. Kare's 50 glorious years of visionary leadership at Indoco
July 02, 2013
Indoco receives ANDA approval for Glimepiride tablets from USFDA
April 18, 2013
Suresh G. Kare to receive the 'Udyog Shree Jeevan Gaurav Sanman' on March 29, 2013 at the hands of Hon'ble Chief Minister of Goa, Mr. Manohar Parrikar
March 22, 2013
Indoco's Chairman Mr. Suresh G. Kare to receive the 'Udyog Shree Lifetime Achievement Award'
February 11, 2013
Indoco Remedies Limited bags award for 'Innovation in Quality’ at CPhI India Pharma Awards 2012
November 27, 2012
Indoco CND, a new division for care in Cardiology and Diabetology
April 4, 2012
Mr. Sundeep V. Bambolkar honoured for the second time at the ‘CFO 100 Awards’ 2012
March 29, 2012
Third Generation takes over the Management reins at Indoco...
February 14, 2012
Change of Company Secretary & Compliance Officer
February 8, 2012
Indoco enters into a marketing and sales alliance with DSM, a € 9 billion Company
January 31, 2012
Indoco Remedies - Fixes Book Closure for Dividend & AGM - BSE ANNOUNCEMENT 
June 24, 2011
Indoco Remedies Board recommends Dividend
May 28, 2011
 
 
Change of Company Secretary & Compliance Officer
February 8, 2012

Indoco Remedies Ltd has informed BSE that Mr. Sunil Joshi has been appointed as Company Secretary & Compliance Officer of the Company w.e.f. February 08, 2012, in place of Mr. Jagdish B. Salian who would retire as Company Secretary & Compliance Officer from February 07, 2012.


^Top
 
 
Indoco enters into a marketing and sales alliance with DSM, a € 9 billion Company
January 31, 2012

Indoco announced the signing of an agreement with DSM for commercial cooperation for eight Active Pharmaceutical Ingredients (APIs). Indoco and DSM have agreed to form a strategic alliance, wherein DSM shall be marketing and selling the APIs manufactured by INDOCO.

In line with Indoco's strategy, this agreement paves the way for Indoco to expand its presence in markets across the globe for APIs and enables Indoco to leverage its product development and cGMP (current Good Manufacturing Practices) compliant manufacturing capabilities.

Mr. Suresh G. Kare, Chairman & Managing Director, Indoco Remedies Ltd., commented, “Today in the era of alliances and partnerships, organizations are coming together to penetrate and capture a larger share of the potential opportunities in the market place. Indoco is active in forging such a lliances and this one with DSM is a step in that direction. This alliance offers a great opportunity to expand our global presence with a well established partner like DSM." Founded in 1947, Indoco Remedies Limited is one of the leading manufacturers of APIs and Finished Dosages in India for various therapeutic classes. USDMFs (US Drug Master Files), CoS (Certificate of Suitability) applications and DMFs ( Drug Master Files) have been filed by Indoco for some APIs and the Company has been seeking to expand supplies to major markets worldwide, including European and US generic and branded pharmaceutical companies.

Alexander Wessels, President and Chief Executive Officer, DSM Pharmaceutical Products (DPP) stated, “This is a step in our announced strategy to accelerate growth via partnerships and expansion in Asia to build a product portfolio alongside our custom manufacturing operations, supplying access to high demand treatments. It allows DPP to build a competence base in India” The Indoco alliance is anchored in DSM's API business, DSM Pharma Chemicals, headquartered in Austria. DSM Pharmaceutical Products is a Business Group of Royal DSM N.V. and is a global science-based company active in health, nutrition and materials. DSM’s 22,000 employees deliver annual net sales of about € 9 billion. The company is listed on NYSE Euronext.

Indoco preferred DSM for this strategic alliance based on DSM’s longstanding pharmaceutical customer contacts and presence in markets worldwide combined with their deep commitment to quality.

About DSM


^Top
 
 
Indoco Remedies - Fixes Book Closure for Dividend & AGM - BSE ANNOUNCEMENT
June 24, 2011

Indoco Remedies Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 21, 2011 to July 28, 2011 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company to be held on July 28, 2011. 


^Top
 
 
Indoco Remedies Board recommends Dividend
May 28, 2011

At the meeting held on May 28, 2011, the Board has decided to recommend a dividend of Rs. 8/- per equity share of Rs. 10/- each of the Company (80%) for the year ended March 31, 2011. The dividend when approved at the AGM will be paid on or after August 08, 2011 to those shareholders whose names appear on the register of members as on the record date.


^Top